CALABRESE, Massimiliano
 Distribuzione geografica
Continente #
NA - Nord America 2.842
EU - Europa 2.596
AS - Asia 1.586
AF - Africa 41
OC - Oceania 11
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.086
Nazione #
US - Stati Uniti d'America 2.831
CN - Cina 912
GB - Regno Unito 553
IT - Italia 488
SG - Singapore 456
RU - Federazione Russa 315
SE - Svezia 306
FR - Francia 255
IE - Irlanda 254
DE - Germania 141
FI - Finlandia 121
VN - Vietnam 69
ID - Indonesia 51
UA - Ucraina 49
TG - Togo 35
KR - Corea 23
HK - Hong Kong 22
BE - Belgio 20
NL - Olanda 18
AT - Austria 12
MK - Macedonia 11
AU - Australia 9
CA - Canada 9
JP - Giappone 9
TR - Turchia 8
HR - Croazia 7
PT - Portogallo 6
ES - Italia 5
PH - Filippine 5
CH - Svizzera 4
IL - Israele 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
BG - Bulgaria 3
BR - Brasile 3
CZ - Repubblica Ceca 3
IN - India 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
AM - Armenia 2
AR - Argentina 2
CL - Cile 2
CY - Cipro 2
DK - Danimarca 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
LT - Lituania 2
LU - Lussemburgo 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
RO - Romania 2
SC - Seychelles 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
EU - Europa 1
IM - Isola di Man 1
JO - Giordania 1
LK - Sri Lanka 1
MA - Marocco 1
MY - Malesia 1
PA - Panama 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 7.086
Città #
Chandler 682
Southend 490
Singapore 374
Ashburn 276
Dublin 250
Beijing 192
Verona 184
Jacksonville 164
Woodbridge 151
Ann Arbor 133
Princeton 100
Redmond 97
Lawrence 93
Wilmington 78
Houston 74
Jinan 70
Helsinki 66
New York 62
Dong Ket 52
Jakarta 51
Nanjing 46
Lancaster 45
Shenyang 44
Sindelfingen 44
Hebei 39
Lomé 35
Redwood City 32
Tianjin 32
Washington 31
Seattle 28
Changsha 25
Haikou 25
Zhengzhou 25
Milan 24
Ningbo 24
Seoul 23
Taizhou 22
Santa Clara 21
Brussels 20
Dallas 20
Guangzhou 19
Nanchang 19
Hong Kong 18
Lappeenranta 18
Norwalk 17
Boardman 14
Hangzhou 14
Los Angeles 14
Dongguan 13
Sant'Ambrogio di Valpolicella 13
Fuzhou 12
Bologna 11
Padova 11
Rome 11
Skopje 11
Fairfield 10
Taiyuan 10
Vienna 10
Amsterdam 9
Jiaxing 9
Bonndorf 8
Chicago 8
Lanzhou 8
Clearwater 7
Falls Church 7
Kent 7
Riva Del Garda 7
Roverbella 7
Cambridge 6
Chirignago 6
Naples 6
Paris 6
San Diego 6
Chions 5
Dearborn 5
Duncan 5
Düsseldorf 5
Iloilo City 5
Trento 5
Boydton 4
London 4
Nuremberg 4
Pordenone 4
Toronto 4
Xiangfen 4
Zurich 4
Atlanta 3
Canberra 3
Chisinau 3
Giv‘atayim 3
Kemerovo 3
Olgiate Olona 3
Parma 3
Porto 3
Riva 3
Saint-Laurent-du-Var 3
Shanghai 3
Sofia 3
Tokyo 3
Valbonne 3
Totale 4.696
Nome #
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 143
QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? 120
Microstructural modulations in the hippocampus allow to characterizing relapsing-remitting versus primary progressive multiple sclerosis 111
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 110
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 110
A case of epilepsy in multiple sclerosis: Three-dimensional double inversion recovery sequences revealed cortical dysplasia 102
A case of acute fulminant multiple sclerosis treated with alemtuzumab 101
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 99
Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest 97
The diagnosis of multiple sclerosis: pinpointing the concept of "no better explanation" 95
Assessing response to interferon-β in a multicenter dataset of patients with MS 95
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 95
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 93
Response to Nagai et al. 91
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 90
The CSF profile linked to cortical damage predicts Multiple Sclerosis activity 89
Iron loss of thalamic nuclei evaluated with quantitative susceptibility mapping is related to intrathecal macrophages activity and cortical pathology of multiple sclerosis 88
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 87
Epilepsy in multiple sclerosis: The role of temporal lobe damage 87
Can DTI and 3D-SHORE based indices differentiate RRMS from PMS Patients? 85
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events 84
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 83
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 83
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 82
Automatic segmentation of gray matter multiple sclerosis lesions on DIR images 82
Increased cortical lesion load and CSF cytokines in oligoclonal band positive MS patients 81
The use of the central vein sign in the diagnosis of multiple sclerosis: a systematic review and meta-analysis 81
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis 79
Heterogeneity of cortical lesion susceptibility mapping in multiple sclerosis 78
Unraveling the MRI-Based Microstructural Signatures Behind Primary Progressive and Relapsing-Remitting Multiple Sclerosis Phenotypes 78
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis 74
Exploring the origins of grey matter damage in multiple sclerosis. 74
Executive functioning affects verbal learning process in multiple sclerosis patients: Behavioural and imaging results 74
Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study 73
Multiple sclerosis and epilepsy: much more than a coincidence 73
The prognostic value of white-matter selective double inversion recovery mri sequence in multiple sclerosis: an exploratory study 73
Cortical lesion counts by double inversion recovery should be part of the MRI monitoring process for all MS patients: yes. 72
Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis 71
Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients 71
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis 70
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI 69
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 68
Cerebrospinal fluid IgM levels in association with inflammatory pathways in multiple sclerosis patients 68
Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients 67
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS 67
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 66
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study 65
Explainable 3D-CNN for multiple sclerosis patients stratication 65
Interpretable Deep Learning as a means for decrypting disease signature in Multiple Sclerosis 65
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study. 64
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: an Italian multi-centre study 64
CSF levels of CXCL12 and osteopontin as early markers of primary progressive multiple sclerosis 64
Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy. 63
The effect of fingolimod on focal and diffuse grey matter damage in active MS patients 63
Lost in classification: lower cognitive functioning in apparently cognitive normal newly diagnosed RRMS patients 63
Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables 62
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 62
A videogame-based approach to measuring information processing speed in multiple sclerosis patients 60
Repeated passive mobilization to stimulate vascular function in individuals of advanced age who are chronically bedridden. A randomized controlled trial 60
Correlating Dti and 3d-Shore Based Indices with Neurological Disability Scores of Multiple Sclerosis Patients 59
Visual-attentional load unveils slowed processing speed in multiple sclerosis patients: a pilot study with a tablet-based videogame 59
A novel prognostic score to assess the risk of progression in relapsing-remitting multiple sclerosis patients 57
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy 56
Multivariate data analysis suggests the link between brain microstructure and cognitive impairment in multiple sclerosis 56
Changes in cerebrospinal fluid balance of TNF and TNF receptors in naïve multiple sclerosis patients: early involvement in compartmentalised intrathecal inflammation 56
The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis 55
Diffusion MRI and silver standard masks to improve CNN-based thalamus segmentation 54
The vascular side of chronic bed rest: when a therapeutic approach becomes deleterious 53
Diagnosis of multiple sclerosis: a multicentre study to compare revised McDonald-2010 and Filippi-2010 criteria 52
Microstructural MRI Correlates of Cognitive Impairment in Multiple Sclerosis: The Role of Deep Gray Matter 52
Coping strategies and their impact on quality of life and physical disability of people with multiple sclerosis 52
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 50
Social cognition deficits and the role of amygdala in relapsing remitting multiple sclerosis patients without cognitive impairment 50
Informing MS patients on treatment options: a consensus on the process of consent taking 50
Cortical gray matter MR imaging in multiple sclerosis 49
False memories in relapsing remitting multiple sclerosis patients: A preliminary investigation with the DRM paradigm 49
Social cognition in multiple sclerosis: a 3-year follow-up {MRI} and behavioral study 49
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis 49
Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis 47
Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration 46
MRI of cortical lesions and its use in studying their role in MS pathogenesis and disease course 45
"What is hidden behind the mask?" Facial emotion recognition at the time of COVID-19 pandemic in cognitively normal multiple sclerosis patients 45
The BAFF / APRIL system as therapeutic target in multiple sclerosis 44
Early multiple sclerosis: diagnostic challenges in clinically and radiologically isolated syndrome patients 44
CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis 42
Evaluation of the central vein sign as a diagnostic imaging biomarker in Multiple Sclerosis 42
Slowing processing speed is associated with cognitive fatigue in newly diagnosed multiple sclerosis patients 42
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group 42
Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis 42
Two years' effect of dimethyl fumarate on focal and diffuse gray matter pathology in multiple sclerosis 41
Explainable deep learning for decrypting disease signatures in multiple sclerosis 38
"Ependymal-in" gradient of thalamic damage in progressive multiple sclerosis 38
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 37
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 36
Imaging and depression in multiple sclerosis: a historical perspective 35
Intrathecal versus peripheral inflammatory protein profile in MS patients at diagnosis: a comprehensive investigation on serum and CSF 35
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity 34
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage 33
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 33
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs 31
Totale 6.628
Categoria #
all - tutte 32.622
article - articoli 29.482
book - libri 0
conference - conferenze 2.926
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 214
Totale 65.244


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020410 0 0 0 0 103 48 74 6 10 52 60 57
2020/2021755 75 107 44 77 95 75 32 20 49 34 68 79
2021/2022870 48 263 5 125 18 19 34 53 27 30 64 184
2022/20231.895 116 244 158 337 129 415 45 114 220 22 53 42
2023/20241.235 38 88 105 132 124 238 102 77 17 94 154 66
2024/20251.123 140 169 144 615 55 0 0 0 0 0 0 0
Totale 7.320